Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney

In France, the second cancer plan of 2009-2013 aimed to strengthen the role of MT by putting it back at the center of patient monitoring, in particular by asking "regional health agencies to encourage and support local experiments" which aim for better coordination between the city and the hospital. The third cancer plan for 2014-2019 insists on this measure because it had proven to be unproductive, and recommends, in addition to the creation of a nurse dedicated to the coordination of care between community medicine and the hospital, the creation of a direct telephone line to reach the hospital medical team. This measure is mainly aimed at the follow-up of certain cancers that do not require the technical support of the hospital, as is the case in the post-operative follow-up of RCC and CaP, where the additional examinations carried out during follow-up are carried out in the city.

The research hypothesis is that this new method of monitoring had a positive impact on care in terms of quality, accessibility, organization and costs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Kidney Cancer Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'Urologie - CHU de Strasbourg - France

Strasbourg, 67091, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult subjects (≥18 years old)
Patient operated on for localized prostate or kidney cancer
Patient followed at the HUS during the period from 01/01/2015 to 12/31/2021
Subject who has not expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

Subject having expressed opposition to participating in the study
Patient under active therapy (hormonotherapy, systemic treatment) for the pathology studied
Impossibility of providing the subject with informed information (difficulties in understanding the subject, etc.)
Subject under judicial protection
Subjects under guardianship or curatorship

Treatment and study plan

Primary outcomes

Evaluation of the economic impact of the treatment of patients operated on for localized prostate or kidney cancer

Time frame: The period concerned is from January 1, 2015 to December 31, 2021.

This study concerns a retrospective evaluation of the economic cost of treatment of localized prostate or kidney cancer in patients followed at the University Hospitals of Strasbourg during the period from January 1, 2015 to December 31, 2021.

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney: A Retrospective Study

Acronym: LiVHOU

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Jan 19, 2024
Registry last updated: Mar 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed